introduction

Industry and Patients Involved: Collaboration of HollandBIO and admedicum

“To offer companies a helping hand with patient engagement, HollandBIO and admedicum teamed up to develop the PEG. The idea was born from Wouter Strijker, at the time with HollandBIO, and Philipp von Gallwitz, Co-Founder of admedicum® Business for Patients, at the Orphan Summit Conference in Amsterdam in late 2016.

The idea was tested and further developed in a workshop with HollandBIO members in The Hague in April 2017. During a webinar in November a demo version was presented to interested members and patient representatives. Feedback from these events and from numerous individual exchanges with patient and industry contributors has been invaluable! An overview of contributors and partners can be found in the section “Thanks to Contributors”.

HollandBIO is the rapidly-growing industry association that represents the interests of biotech companies in The Netherlands. It's members reflect the biotech sector: from start-ups and SMEs to large companies, active in healthcare, agri-food or biobased economy. HollandBIO­­­ actively looks after the sector’s interests and supports a strong network. By tackling the obstacles that hinder the biotech sector's ambitions, HollandBIO ensures that biotech innovations can be made available as quickly and widely as possible.

admedicum® Business for Patients is a rapidly-growing European group of patient engagement experts. The company has been founded on the conviction that biopharma has to integrate patients as key stakeholders into the learning and decision making process along the value chain. However, partnering with patients is complex and new to many. admedicum specializes exclusively on helping companies with identifying valuable opportunities to work with patients and making it happen.